A

Alpine Immune Sciences, Inc.

123 employees

Leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2015

Funding rounds raised

Total raised

$91M

from 17 investors over 17 rounds

A

Alpine Immune Sciences, Inc. raised $91M on September 15, 2021

Investors: OrbiMed Advisors, Decheng Capital, Logos Global Management, LP, TCG X, Avidity Partners, Omega Funds and Frazier Healthcare Partners

A

Alpine Immune Sciences, Inc. raised $60M on July 24, 2020

Investors: Omega Funds, Avidity Partners and Samsara BioCapital

A

Alpine Immune Sciences, Inc. raised $25M on January 16, 2019

Investors: OrbiMed Advisors, Decheng Capital, Frazier Healthcare Partners and Alpine BioVentures

A

Alpine Immune Sciences, Inc. raised $48M on June 13, 2016

Investors: OrbiMed Advisors, Alpine BioVentures and Frazier Healthcare Partners

FAQ